AB Vista is an animal nutrition technology company offering pioneering products and technical services to the global animal feed industry. With its headquarters in the UK, the company employs over 190 staff globally and has support offices worldwide.
Assess feed quality to make smarter nutritional and commercial decisions.
Measure enzyme activity to ensure consistent quality control.
Optimise the feed manufacturing process.
AB Vista is committed to facilitating discussions around animal nutrition technology and gathering experts to provide independent opinions.
Our ultimate aim is to research and apply science that brings real value commercially to the animal production industry.
Stay ahead with the latest news, ideas and events.
AB Vista is committed to bringing new ways of thinking to the global feed industry. Our work attracts enquiring minds who see things differently and embrace the changing landscape – offering our clients an interested, innovative and up-to-date partner.
Thursday, January 28, 2016
In a recently released technical video, Mike Bedford, Research Director at AB Vista, highlights new research that more precisely identifies how phytases work in the animal.
READ MORE ▶
Monday, January 25, 2016
Superdosing – where are the benefits coming from? Part one: complete phytate destruction
Thursday, January 21, 2016
New research from AB Vista shows that thermostability of xylanase plays a critical role in ensuring consistent performance improvements in poultry.
Thursday, January 7, 2016
AB Vista is launching a technical video series at this year’s International Production and Processing Expo (IPPE) in January, aimed at sharing information on various key areas of development within animal nutrition technology for 2016.
Friday, January 1, 2016
Econase GT is a β-glucanase that specifically targets β-glucans found within barley and oat-based diets.
A regular summary of our key stories sent straight to your inbox.
Receive a regular summary of our key stories sent straight to your inbox.
© AB Vista. All rights reserved 2019
A regular summary of our key stories sent straight to your inbox